5 new cases of COVID-19 out of 608 tested; CAR score 0.2

230

Five (5) new cases of COVID-19 were identified out of 608 tests performed by the Department of Public Health and Social Services (DPHSS) on Sunday, March 14, and tests from additional labs from Friday, March 12 to Sunday, March 14. Three (3) cases reported recent travel history and were identified in quarantine.

To date, there have been a total of 7,773 officially reported cases of COVID-19 with 134 deaths, 27 cases in active isolation, and 7,612 not in active isolation.

TODAY’S CAR SCORE

0.2

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results reported to the JIC on Monday, March 15, and reflects results additional labs from Friday, March 12 to Sunday, March 14:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,773

5

22

CONFIRMED CASES:

7,563

5

21

PROBABLE CASES:

210

0

1

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

133,082

608

1.3%

MOLECULAR TESTS

123,339

560

1.3%

ANTIGEN TEST

9,743

48

0.8%

SEROLOGY TESTS

360

1

50%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

134

Hospital

5

Active Isolation

27

Home

11

Not In Isolation

7,612

Isolation Facility

6

Civilian

7,380

Military

5

Military Service Member

393

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

5

0

0

5

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

The following provides preliminary COVID-19 vaccinations reported to the JIC on Monday, March 15, for vaccinations administered from December 17 to March 14:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Total Doses Administered

Individuals Fully Immunized

Pfizer-BioNTech

17,634

15,359*

32,993

15,359

Moderna

16,032**

13,775***

29,807

13,775

Johnson & Johnson Janssen

0

0

TOTALS:

33,666

29,134

62,800^

29,134

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

62,800^

87,860^^

71.48%

25,060

^As of March 14, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states “After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 603)

##